APA (7th ed.) Citation

SW, G., 3rd, M. W., DA, S., RK, S., HM, L., SC, M., . . . AS, P. (2019). Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma. American journal of clinical oncology, 42(8), 649. https://doi.org/10.1097/COC.0000000000000567

Chicago Style (17th ed.) Citation

SW, Gordon, et al. "Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma." American Journal of Clinical Oncology 42, no. 8 (2019): 649. https://doi.org/10.1097/COC.0000000000000567.

MLA (9th ed.) Citation

SW, Gordon, et al. "Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma." American Journal of Clinical Oncology, vol. 42, no. 8, 2019, p. 649, https://doi.org/10.1097/COC.0000000000000567.